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In a recent report, Toxicity Testing in the 
21st Century, the National Research Council 
Committee on Toxicity Testing and Assessment 
of Environmental Agents (2007) proposed that 
improved scientific understanding of toxic-
ity pathways was central to the expanded use 
of predictive, pathway-based bioassays in risk 
assessment. Toxicity pathways can be viewed 
as the series of biological changes, spanning 
across multiple levels of biological organization, 
that lead from some molecular initiating event 
(perturbation) to an adverse outcome. A major 
challenge associated with dose–response model-
ing and extrapolation from laboratory to real-
world conditions has been to understand under 
what conditions an organism may compensate 
for, or recover from, a given perturbation and 
under what conditions the perturbation will 
lead to an adverse outcome (Andersen et al. 
2005). Thus, in developing useful predictive 
models of toxicity, we need to understand not 
only the direct effects of a chemical and how 
they translate into adverse effect, but also the 
potential mechanisms for compensation and 
recovery and how they may intersect with other 
biological pathways and processes. 
Previous studies with the fathead minnow 
(Pimephales promelas) have suggested potential 
compensatory responses to the direct effects of 
chemicals whose primary mode of action was 
inhibition of one or more enzymes involved in 
steroid biosynthesis. For example, the chemical 
fadrozole (FAD) inhibits aromatase, the enzyme 
that catalyzes the rate-limiting conversion of 
testosterone (T) to 17β-estradiol (E2) (Miller 
1988). Villeneuve et al. (2006) observed signifi-
cant, concentration-dependent up-regulation 
of transcripts coding for the ovarian isoform of 
aromatase (CYP19A) in female fathead min-
nows exposed to FAD for 7 days. The increased 
CYP19A gene expression was associated with 
an inverted U-shaped concentration–response 
profile for ovary aromatase activity. Although 
that study did not examine effects on plasma E2 
concentrations, it was noted that the responses 
would favor increased synthesis of E2 to poten-
tially offset the effect of FAD on aromatase. In 
another study, Ankley et al. (2007) exposed 
fathead minnows to the steroido  genesis inhib-
itor keto  conazole for 21 days. Testosterone 
production by testis or ovary tissue collected 
from ketoconazole-exposed fish was signifi-
cantly reduced compared with control fish. 
However, there was significant up-regulation 
of genes coding for cytochrome P450 choles-
terol side-chain cleavage (P450scc, CYP11A) 
and cytochrome P450 c17αhydroxylase, 
17,20-lyase, and concentration-dependent 
proliferation of steroid-producing interstitial 
cells in the testis of exposed males. As a result, 
plasma T and E2 concentrations in exposed 
fish were similar to those of controls, despite 
the decreased rate of steroid production per 
unit mass of tissue, suggesting a compensatory 
response to ketoconazole (Ankley et al. 2007). 
Both the FAD and ketocona  zole studies sug-
gest that fish have the capacity to adapt to and 
potentially recover from the direct effects of 
steroidogenesis inhibitors. 
Aromatase is a key steroidogenic enzyme 
shown to be subject to inhibition, at least 
in vitro, by a variety of chemicals present in 
the environment, including certain pesticides, 
organochlorines, and organotins (Sanderson 
2006). The aim of this study was to develop a 
more comprehensive understanding of molec-
ular and biochemical responses of fathead 
minnows to aromatase inhibition, including 
direct effects, compensation, and/or recovery. 
We examined a time course of selected gene 
expression and biochemical responses over the 
course of an 8-day waterborne exposure to two 
concentrations of FAD, followed by an 8-day 
recovery period in control water. The experi-
ment was designed to test several hypotheses:
•	FAD would elicit direct effects consistent 
with its presumptive mode of action
•	Over time, there would be compensatory 
molecular responses in females, consistent 
with an attempt to increase E2 synthesis
•	Compensatory effects at the molecular level 
would correspond to changes in circulating 
E2 and/or rates of ex vivo E2 production
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Ba c k g r o u n d: Several chemicals in the environment have the potential to inhibit aromatase, an 
enzyme critical to estrogen synthesis. 
oBjectives: The objective of this study was to provide a detailed characterization of molecular and 
biochemical responses of female fathead minnows to a model aromatase inhibitor, fadrozole (FAD). 
Me t h o d s : Fish were exposed via water to 0, 3, or 30 µg FAD/L for 8 days and then held in clean 
water for 8 days, with samples collected at four time points during each 8-day period. We quanti-
fied ex vivo steroid production, plasma steroids, and plasma vitellogenin (Vtg) concentrations and 
analyzed relative transcript abundance of 10 key regulatory genes in ovaries and 3 in pituitary tissue 
by real-time polymerase chain reaction. 
re s u l t s: Ex vivo 17β-estradiol (E2) production and plasma E2 and Vtg concentrations were sig-
nificantly reduced after a single day of exposure to 3 µg or 30 µg FAD/L. However, plasma E2 
concentrations recovered by the eighth day of exposure in the 3-µg/L group and within 1 day of ces-
sation of exposure in the 30-µg/L group, indicating concentration- and time-dependent physiologic 
compensation and recovery. Concentration-dependent increases in transcripts coding for aromatase 
(A isoform), cytochrome P450 side-chain cleavage, steroidogenic acute regulatory protein, and 
follicle-stimulating hormone receptor all coincided with increased E2 production and recovery of 
plasma E2 concentrations. 
co n c l u s i o n s: Results of this research highlight the need to consider compensation/adaptation and 
recovery when developing and interpreting short-term bioassays or biomarkers or when trying to 
predict the effects of chemical exposures based on mode of action. 
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•	Effects	would	be	time	and	concentration	
dependent
•	There	would	be	recovery	after	cessation	of	
FAD exposure.
Although FAD is a drug with no direct 
environmental relevance, its specificity makes 
it a useful model chemical for studying this 
mode of action. Results of this study provide 
an improved understanding of the dynamics 
of biological response to this chemical, and 
its removal. This knowledge will contribute 
to formulation of a robust, biologically based 
toxicity pathway model for the effects of estra-
diol synthesis inhibitors. 
Materials and Methods
Chemical and test organisms. FAD was pro-
vided by Novartis, Inc. (Summit, NJ). All 
fish used in the study were reproductively 
mature adult fathead minnows (5–6 months 
of age) obtained from an onsite culture facil-
ity at the U.S. EPA Mid-Continent Ecology 
Division (Duluth, MN). All animals were 
treated humanely and with regard for alle-
viation of suffering, and all laboratory pro-
cedures involving animals were reviewed 
and approved by the Animal Care and Use 
Committee in accordance with Animal 
Welfare Act and Interagency Research Animal 
Committee guidelines. 
FAD exposure. We conducted exposures 
in 20-L glass aquaria containing 10 L ultra-
violet light–treated, membrane filtered, Lake 
Superior water containing nominal concentra-
tions of 0, 3.0, or 30 µg FAD/L. All treatments 
were delivered via water at a continuous flow of 
approximately 45 mL/min without the use of 
carrier solvents. Toxicant (and control water) 
delivery was initiated to 16 replicate tanks per 
treatment group approximately 48 hr prior 
to test initiation to ensure that stable FAD 
concentrations were achieved before adding 
fish. Exposures were then initiated (day 0) by 
transferring random groups of four male and 
four female fathead minnows to each tank. 
Fish addition times were staggered by replicate 
within each treatment to permit all samples 
from a given exposure tank to be collected 
within 40 min of the target exposure duration. 
Immediately after fish addition, each tank was 
furnished with four breeding substrates (poly-
vinyl chloride tiles). Fathead minnows are a 
repeat-spawning fish species with asynchronous 
oocyte development that, under optimal condi-
tions, can spawn every 3–5 days in the labora-
tory (Jensen et al. 2001). Males aggressively 
defend breeding substrates, particularly when 
fertilized eggs are present. Although reproduc-
tion (e.g., spawning activity, fecundity) was 
not considered a primary end point in this 
study design, supplying at least one breeding 
substrate per male promotes normal reproduc-
tive behaviors, provides refuge, and minimizes 
aggressive behavior among males. 
After 24, 48, 96, and 192 hr of exposure 
(days 1, 2, 4, 8), we sampled fish from two 
replicate tanks per treatment group (a total 
of eight males and eight females per treat-
ment per time point). On day 8, we termi-
nated chemical delivery to the unsampled 
tanks such that all groups received FAD-free 
Lake Superior water for the remainder of the 
experiment. Sampling continued at inter-
vals consistent with those used on days 1–8 
of exposure (i.e., days 9, 10, 12, 16). Given 
this exposure and sampling design, days 1–8 
are subsequently described as the “exposure” 
period of the experiment and days 9–16 are 
described as the “recovery” period.
During each sampling period, the fish were 
euthanized in a buffered solution of tricaine 
methanesulfonate (MS-222; Finquel; Argent, 
Redmond, WA), and the time at which indi-
vidual fish were euthanized was recorded. We 
measured whole-body wet weight. Urine was 
expelled from males by applying gentle pres-
sure on the fish’s abdomen and samples were 
collected using nonheparinized microcapillary 
tubes. We noted the presence or absence of 
sperm in the urine sample, and samples were 
stored at –80°C for future metabolomic analy-
ses (e.g., Ekman et al. 2007). Blood was col-
lected from males and females using heparinized 
micro  hematocrit tubes, and plasma was sepa-
rated by centrifugation. Plasma samples were 
stored at –80°C until extracted and analyzed. 
After biofluid sampling, liver, gonads, brain, 
and pituitary were removed. Liver samples 
were transferred to preweighed micro  centrifuge 
tubes containing a stainless steel bead (3.2 mm; 
Biospec Products, Bartlesville, OK) to aid later 
homogenization and immediately snap-frozen 
in liquid nitrogen. Whole gonads were weighed 
and divided into several pieces. The left gonad 
was split into two sub  samples of approximately 
equal size, and each subsample was placed in 
a pre  weighed micro  centrifuge tube contain-
ing a stainless steel bead and snap-frozen in 
liquid nitrogen; the anterior half was allocated 
for metabolomics analysis (to be reported else-
where) and the posterior half used for RNA 
extraction. The posterior half of the right gonad 
was preserved in Davidson’s fixative for later 
histologic characterization, and a subsample of 
the anterior portion of the right gonad was used 
for an ex vivo steroid production assay. Brains 
were transferred to preweighed microcentrifuge 
tubes containing a stainless steel bead and snap-
frozen in liquid nitrogen. Pituitary samples 
were collected with fine forceps, preserved in 
RNAlater (Ambion, Austin, TX) and stored at 
–20°C. All dissection tools were washed with 
RNaseZap (Ambion) between each sample to 
prevent cross-contamination or degradation 
by RNAses. 
We quantified FAD concentrations in all 
test tanks containing fish on each sampling day 
of the exposure period (days 1, 2, 4, 8). Water 
samples collected from the tanks were analyzed 
by HPLC (model 1100; Agilent, Wilmington, 
DE). Samples (300 µL) were injected onto 
a 2.0 × 75 mm Synergi Hydro RP column 
(Phenomenex, Torrance, CA) and eluted iso-
cratically with 57% methanol/phosphate buffer 
(50 mM, pH 7.0) at a flow rate of 0.25 mL/
min. We determined concentrations using a 
diode array absorbance at 230 nm. Tanks were 
also sampled on the first day of the recovery 
period (day 9) to determine whether FAD con-
centrations had diminished to non  detectable 
levels (method detection limit = 1 µg/L). Mean 
± SD temperature, dissolved oxygen, and pH 
monitored during the exposure and recovery 
periods were 25.1 ± 0.2°C, 6.66 ± 0.55 mg/L, 
and 7.5 ± 0.05, respectively. 
Biochemical analyses. We conducted 
ex vivo steroid production assays using meth-
ods adapted from McMaster et al. (1995) 
as described previously (Ankley et al. 2007; 
Martinovic et al. 2008). Subsamples of gonad 
[15.4 ± 8.8 mg for ovary; 6.5 ± 4.0 mg for 
testis (mean ± SD)] were transferred to glass 
test tubes containing 500 µL Medium 199 
(M2520; Sigma, St. Louis, MO) supple-
mented with 0.1 mM isobutyl  methyl  xanthine 
(IBMX; Sigma I7018) and 1 µg 25-hydroxy-
cholesterol (Sigma) per milliliter, on ice. At 
the end of each sample collection period, the 
tubes were transferred to a 25oC shaker water 
bath and incubated for 12 hr. After incuba-
tion, the medium from each tube was collected 
and stored at –20°C until analyzed, and the 
tissue subsample from each tube was removed 
and weighed. Tubes containing supplemented 
medium but no tissue were incubated, sam-
pled, and analyzed along with experimental 
samples to serve as assay blanks. 
Steroids were extracted from medium 
samples (ex vivo) or plasma samples by liquid–
liquid extraction with diethyl ether and then 
quantified by radioimmunoassay (RIA) (Jensen 
et al. 2001; U.S. EPA 2002). In the case of the 
medium samples, E2 and T were measured for 
ovary incubations, but only T was analyzed 
for the testis incubations (unpublished data 
indicate that E2 production by testis samples 
is generally below detection limits). In general, 
plasma sample volumes were not sufficient to 
facilitate the analysis of more than one steroid; 
therefore, E2 was quantified for females and 
T was quantified for males. We quantified 
plasma concentrations of the estrogen-induc-
ible egg yolk precursor protein vitellogenin 
(Vtg) by ELISA using a polyclonal antibody 
to fathead minnow Vtg and purified fathead 
minnow Vtg as a standard (U.S. EPA 2002). 
Quantitative real-time PCR analyses. We 
analyzed gene expression in selected ovary and 
pituitary samples using quantitative real-time 
polymerase chain reaction (QPCR). Total 
RNA was extracted from ovary samples using 
TRI Reagent (Applied Biosystems/Ambion, Villeneuve et al.
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Austin, TX) with minor modifications to the 
manufacturer’s protocol. Samples were homog-
enized in 1.0 mL TRI Reagent using a Retsch 
MM300 mixer mill (Retsch Inc., Newtown, 
PA, USA) (30 Hz for 5 min with 3.2 mm 
stainless steel bead). After extraction, total 
RNA pellets were resuspended in RNAsecure 
and DNase treated using DNA-free (both from 
Applied Biosystems/Ambion) following the 
manufacturer’s protocol. The RNA samples 
were then quantified spectro  photometrically, 
with absorbance at 260 and 280 nm used as 
a meas  ure of relative purity and quantity. We 
analyzed RNA samples for structural integrity 
using glyoxal agarose gel electrophoresis. Total 
RNA was extracted from individual pituitary 
samples using RNeasy micro kits (Qiagen, 
Valencia, CA). The quality and approximate 
concentrations of pituitary RNA were evalu-
ated using a Nanodrop ND-1000 spectropho-
tometer (Nanodrop Technologies, Wilmington, 
DE) and an Agilent 2100 Bioanalyzer (with an 
RNA Pico LabChip kit; Agilent, Palo Alto, 
CA). Pituitary RNA samples were diluted to 
approximately 2 ng total RNA/µL for use in 
the QPCR assays. Ovary RNA samples were 
diluted to 10 ng total RNA/µL. Extracted total 
RNA was stored at –80°C until subsequent use.
Development of QPCR assays for fathead 
minnow CYP19A, follicle-stimulating hormone 
(FSH) receptor (FSHR), CYP11A, steroido-
genic acute regulatory protein (StAR), andro-
gen receptor (AR), luteinizing hormone (LH) 
receptor (LHR), 20β hydroxysteroid dehydro-
genase (20βHSD), LH β subunit (LH-β), and 
FSH β subunit (FSH-β) has been described 
previously (Martinovic et al. 2008; Villeneuve 
et al. 2006, 2007b, 2007d). Additional QPCR 
assays for fathead minnow transcripts coding 
for activin βA, progesterone membrane recep-
tor α (PMR-α), activin receptor IIB (activin 
RIIB), and follistatin were developed as part 
of this work [see Supplemental Material (avail-
able online at http://www.ehponline.  org/  mem-
bers/  2008/  11891/suppl.pdf)]. All assays were 
single-step real-time PCR assays conducted in 
a 96-well format using Taqman EZ RT-PCR 
kits (Applied Biosystems, Foster City, CA). 
Each 25-µL reaction contained either 50 ng 
(ovary) or 10 ng (approximate; pituitary) 
total RNA, 150 nM of the appropriate probe 
(except for FSH-β, 300 nM), 200 nM forward 
primer, and 200 nM reverse primer. Samples 
were reverse-transcribed (50°C for 2 min, 
60°C for 30 min, 95°C for 5 min), followed 
immediately by 40 cycles of PCR amplifica-
tion (melt 94°C for 20 sec, anneal and extend 
58°C for 60 sec) using a 7500 Real-Time PCR 
system (Applied Biosystems). A standard curve 
of known molar quantities of gene-specific 
mRNA standard (10-fold dilution series, gener-
ally 50 to 5 × 107 copies) was used to calibrate 
the QPCR data, and values interpolated from 
the standard curve were normalized to the mass 
of total RNA in the reaction and expressed as 
copies mRNA per nanogram total RNA for 
each sample. Because pitui  tary RNA concen-
trations were approxi  mate, pituitary QPCR 
data were also normalized on a per-sample 
basis to the abundance of ribosomal protein 
L8 (RPL8) transcripts measured in a separate 
QPCR assay. Replicate (n = 2–4) analyses were 
conducted for a minimum of three samples 
per assay (96-well plate) to facilitate estimation 
of intra  assay variability. Intraassay coefficients 
of variation (CVs) were < 10% except for the 
activin βA assay, which had a mean (± SD) 
intraassay CV of 13.2 ± 10.5% (n = 6 samples 
analyzed in triplicate). The greater variability of 
the activin βA assay was likely due to the fact 
that the low abundance (~ 500–5,000 tran-
scripts/ng total RNA) of activin βA transcripts 
in ovary required greater amplification before a 
signal was detected [threshold cycle (Ct) values 
33–36] compared with the other QPCR assays 
(Ct around 22–28). 
Data analysis. In general, samples from all 
three treatment groups (0, 3, 30 µg FAD/L, 
nominal) per time point were analyzed in the 
same assay (e.g., QPCR, RIA), whereas sam-
ples from different time points were analyzed 
in two to four independent assays. As a result, 
inter  assay variability did not confound statisti-
cal comparison among chemical treatments 
but could confound comparisons among time 
points. Therefore, unless otherwise stated, sta-
tistical analyses were focused on treatment 
comparisons within, rather than between, 
time points, and data are presented as fold-
change (log 2) relative to the control mean for 
a given time point. Statistical analyses were 
conducted prior to conversion to fold-change 
(log 2) units.
We evaluated data normality and homoge-
neity of variance using a Kolmogorov-Smirnov 
test and Levene’s test, respectively. When data 
conformed to parametric assumptions, one-
way analysis of variance (ANOVA) was used 
to test for differences across chemical treat-
ment groups, and Duncan’s multiple range 
test was used to determine differences between 
chemical treatments. In cases where data did 
not meet parametric assumptions, data were 
either transformed (generally log 10) and ana-
lyzed as described above or were analyzed using 
a nonparametric Kruskal–Wallis test followed 
by Dunn’s non  parametric post hoc test. We 
used general linear models ANOVA to test for 
differences in fish mass and gonadal-somatic 
index (GSI) as a function of both chemical 
treatment, time point, and the inter  action of 
those variables. Differences were considered 
significant at p < 0.05 unless otherwise noted. 
Correlations between GSI, plasma Vtg and 
E2, ex vivo E2 production, and ovarian gene 
expression end points (14 variables total) were 
examined using multi  variate, correlation-
based [mean centered and auto/unit variance 
scaled (van den Berg et al. 2006)] principal 
components analysis (PCA), based on data 
from days 1, 4, 8, 9, 12, and 16 (for six genes, 
QPCR data were not generated for day 2 and 
day 10 samples). PCA was based on a total 
of 136 cases, and missing data points (due 
Figure 1. Ex vivo E2 (A) and T (B) production, and plasma E2 (C) and Vtg (D) measured in female fathead 
minnows exposed to 0 (control), 3, or 30 µg FAD/L and sampled on days 1, 2, 4, or 8 of the exposure period 
or on days 9, 10, 12, or 16 of the recovery period. Data are expressed as fold-change (log 2) relative to the 
control mean measured on a given day; error bars indicate the SE for 7–8 (ex vivo), 4–8 (plasma Vtg), or 
3–8 (plasma E2) replicate fish. 
*p < 0.05 for 3 µg FAD/L compared with control. #p < 0.05 for 30 µg FAD/L compared with control. 
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to technical errors during sample collection, 
extraction, or analysis) were handled through 
mean substitution (mean for that variable 
across all treatments and time points). We con-
ducted statistical analyses using SAS 9.0 (SAS 
Institute Inc., Cary, NC), Statistica 8 (StatSoft 
Inc., Tulsa, OK), and GraphPad Instat v. 3.01 
(GraphPad Software, San Diego, CA). 
Results
FAD concentrations measured in water sam-
ples collected from the exposure tanks were 
slightly higher than the nominal target concen-
trations but were quite stable over the course 
of the 8-day exposure period. Mean (± SD) 
concentrations in the 3-µg FAD/L nominal 
treatment group were 4.2 ± 0.2, 4.0 ± 0.3, 
4.1 ± 0.1, and 4.7 ± 0.1 µg/L on days 1, 2, 4, 
and 8, respectively. Mean (± SD) concentra-
tions in the 30-µg FAD/L nominal treatment 
group were 34.6 ± 1.6, 33.6 ± 1.4, 33.0 ± 2.8, 
and 32.3 ± 2.6 on days 1, 2, 4, 8, respectively. 
No replicate tanks within a treatment devi-
ated > 2 SDs from the mean, and no FAD was 
detected in water samples from control tanks. 
After cessation of FAD delivery, we detected 
no FAD in water samples collected from the 
exposure tanks on the first day of the recovery 
period (day 9). Therefore, we assumed FAD 
concentrations to be < 1.0 µg/L (method detec-
tion limit) for the remainder of the experiment. 
FAD exposure did not significantly affect 
fathead minnow survival (> 99.5%) or mor-
phologic parameters (e.g., body mass, GSI). 
Fish mass did not vary significantly as a func-
tion of chemical treatment group; however, 
males sampled on day 8 (mean ± SD, 2.99 
± 0.71 g) were significantly larger than those 
sampled on other days of the exposure and 
recovery periods (2.54 ± 0.56 g all other days) 
with the exception of day 12. Mean (± SD) 
female mass (1.25 ± 0.28 g) did not vary sig-
nificantly as a function of treatment or time. 
Similarly, we found no significant differences 
in GSI among either males or females. 
FAD exposure did not cause any obvi-
ous effects on fish feeding, swimming, or 
social behaviors. Over the course of the study 
(exposure and recovery phases), we noted 
four spawning events (207 eggs total) in the 
controls, four (52 eggs total) in the 3-µg/L 
group, and no spawns in the 30 µg/L group. 
However, given the design, reproduction data 
were not evaluated statistically. 
Steroids and Vtg. Exposure to FAD had 
significant concentration- and time-dependent 
impacts on ex vivo steroid production by ovary 
tissue (Figure 1A, B). Twenty-four hours of 
exposure to either 3 or 30 µg FAD/L reduced 
ex vivo E2 production to 65 and 15% of control 
production, respectively. In the 30-µg FAD/L 
treatment, that effect appeared to lessen on 
days 2 and 4 of the exposure; by the eighth day 
of exposure, no significant treatment-related dif-
ferences in ex vivo E2 production were detected. 
After cessation of FAD exposure, ex vivo E2 pro-
duction by ovary tissue from the FAD-treated 
fish was generally greater than that by ovary 
tissue from controls. Ex vivo T production by 
ovary tissue was also affected by FAD treat-
ment. Exposure to 30 µg FAD/L resulted in 
a significant increase in ex vivo T production 
throughout the exposure period and three of 
the four recovery period time points. With the 
exception of the T production by ovary tissues 
collected on day 16 (day 8 of recovery period), 
the lesser FAD concentration did not cause 
similar effects on ex vivo T production. 
Alterations in ex vivo steroid production 
corresponded with impacts on circulating 
E2 and Vtg concentrations in female plasma 
(Figure 1C, D). Within 24 hr of exposure, 
both concentrations of FAD caused signifi-
cant reductions in plasma E2 concentrations. 
Even greater depression was observed after 
48 hr of exposure. However, on days 4 and 8, 
plasma E2 concentrations in fish exposed to 
3 µg FAD/L recovered, whereas those in fish 
exposed to 30 µg/L remained depressed. After 
cessation of FAD exposure, plasma E2 concen-
trations rebounded to control levels within the 
first day of recovery in the 30-µg/L treatment 
group, whereas females from the 3-µg/L group 
had elevated E2 concentrations relative to the 
controls and then returned to control levels by 
the second day of the recovery period. Both 
concentrations of FAD depressed plasma Vtg 
concentrations throughout most of the expo-
sure and recovery periods. There was a clear 
concentration-dependent difference in the 
magnitude of depression, but with the excep-
tion of day 2, the time-dependent profile of 
relative Vtg concentrations was largely paral-
lel. Overall, the E2 and Vtg data indicate a 
dynamic biological response to both the pres-
ence of the chemical and its removal.
Although FAD exposure had some signifi-
cant effects on T and Vtg in males, the impacts 
were less substantial and trends were less clear 
than those observed for females. Exposure 
to 30 µg FAD/L appeared to increase mean 
ex vivo T production by testis tissue sampled 
from exposed fish; however, the effect was 
statistically significant on day 2 only, and 
production was variable during the recovery 
period (Figure 2A). Plasma T concentra-
tions tended to follow a profile similar to that 
observed for ex vivo T production, and T con-
centrations measured in the plasma of males 
from the 30-µg/L treatment group sampled 
on days 1, 4, and 12 were significantly greater 
than those in control fish (Figure 2B). Vtg 
concentrations detected in male plasma (0.025 
± 0.27 mg/mL) were, on average, over 400-
fold less than those detected in female plasma 
(11.1 ± 10 mg/mL). However, given the low 
background Vtg concentrations in males (near 
method detection limit), significant depression 
would be difficult to detect in males. Overall, 
we found no obvious relationship between the 
effects on ex vivo T production or plasma T 
and the variations in Vtg observed in males. 
Because of the relative lack of response of the 
males to the aromatase inhibitor both ex vivo 
and in vivo, subsequent gene expression work 
focused on females.
Gene expression. We used real-time PCR 
to examine the effect of FAD exposure on 
the relative abundance of mRNA transcripts 
coding for 13 proteins thought to play impor-
tant roles in regulating reproduction in female 
fish (Villeneuve et al. 2007c). Among the 
10 transcripts examined in the ovary, 4 were 
significantly up-regulated at two or more time 
Figure 2. Ex vivo T production (A), plasma T (B), and plasma Vtg (C) measured in male fathead minnows exposed to 0 (control), 3, or 30 µg FAD/L and sampled on 
days 1, 2, 4, or 8 of the exposure period or on days 9, 10, 12, or 16 of the recovery period. Data are expressed as fold-change (log 2) relative to the control mean 
measured on a given day; error bars indicate the SE for 7–8 replicate fish. 
*p < 0.05 for 3 µg FAD/L compared with control. #p < 0.05 for 30 µg FAD/L compared with control. 
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points during the exposure period (Figure 3). 
CYP19A gene expression was significantly 
up-regulated by day 2 in the 30-µg FAD/L 
treatment group and by day 4 in the 3-µg/L 
group. Expression remained elevated in both 
groups through the first day of the recovery 
period (day 9), then returned to control levels 
in the 3-µg/L group while remaining elevated 
in the 30-µg/L group throughout most of 
the recovery period (Figure 3A). Exposure to 
30 µg FAD/L caused elevated FSHR expres-
sion throughout the entire exposure and recov-
ery period, making it one of the most robust 
molecular responses to the chemical. At the 
lesser exposure concentration, FSHR induc-
tion occurred, but the effect was less rapid 
(significant on day 4 rather than day 1) and 
less persistent, with expression returning to 
control levels by the fourth day of the recov-
ery period (day 12; Figure 3B). CYP11A and 
StAR transcripts were also induced at multiple 
time points. CYP11A was up-regulated in the 
30-µg/L group on days 4 and 8 of the expo-
sure period, as well as 8 days after cessation 
of FAD delivery (day 16) and in the 3-µg/L 
group on the first day of the recovery period 
(day 9). StAR expression was significantly 
greater in the ovaries of fish exposed to 30 µg 
FAD/L for 24 hr and in fish exposed to 3 or 
30 µg FAD/L for 4 days than in control fish. 
Among the other six genes examined 
in ovary tissue, four were up-regulated, but 
only at a single time point (Figure 4). AR and 
activin βA were significantly up-regulated in 
the ovaries of fish exposed to FAD (3 and 
30 µg/L for AR; 30 µg/L only for activin βA) 
after 4 days of exposure. In contrast, LHR and 
PMR-α expression was elevated after 8 days 
of exposure, and only in the ovaries of fish 
exposed to 30 µg FAD/L. Two of the genes 
examined, activin RIIB and 20βHSD, were 
not affected at any of the time points analyzed.
We examined expression of FSHβ, LHβ, 
and follistatin mRNA in the pituitary for three 
time points during the exposure period (days 1, 
4, and 8) (Figure 5). FSH-β expression was 
unaffected by FAD exposure, but LHβ tran-
scripts were significantly less abundant in the 
pituitaries of females exposed to 30 µg FAD/L 
than they were in pituitaries from control fish. 
Follistatin expression had a very different pro-
file: Follistatin transcripts were elevated in the 
pituitaries of females exposed to 3 µg FAD/L 
for 24 hr but were unaffected at the greater 
concentration and at other time points. 
Figure 3. Relative abundance of mRNA transcripts coding for CYP19A (A), FSHR (B), CYP11A (C), and 
StAR (D) measured in ovary from female fathead minnows exposed to 0 (control), 3, or 30 µg FAD/L and 
sampled on days 1, 2, 4, or 8 of the exposure period or on days 9, 10, 12, or 16 of the recovery period. Data 
are expressed as fold-change (log 2) relative to the control mean measured on a given day; error bars indi-
cate the SE for 5–8 replicate fish. 
*p < 0.05 for 3 µg FAD/L compared with control. #p < 0.05 for 30 µg FAD/L compared with control. 
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Figure 4. Relative abundance of mRNA transcripts coding for AR (A), LHR (B), activin βA subunit (C), activin RIIB (D), PMR-α (E), and 20βHSD (F) measured in ovary 
tissue from female fathead minnows exposed to 0 (control), 3, or 30 µg FAD/L and sampled on days 1, 4, or 8 of the exposure period or on days 9, 12, or 16 of the 
recovery period. Data are expressed as fold-change (log 2) relative to the control mean measured on a given day; error bars indicate the SE for 5–8 replicate fish. 
*p < 0.05 for 3 µg FAD/L compared with control. #p < 0.05 for 30 µg FAD/L compared with control. 
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Discussion
Direct effects. The effects of FAD on ex vivo 
E2 production, plasma E2, and plasma Vtg 
in female fathead minnows were consistent 
with FAD’s anticipated mode of action. 
Aromatase catalyzes the conversion of C19 
androgens such as T into C18 estrogens such 
as E2 (Miller 1988; Simpson et al. 1994). 
Consequently, we expected exposure to an 
aromatase inhibitor such as FAD to impair 
this conversion, causing a reduction in the rate 
of E2 synthesis. Consistent with this expecta-
tion, exposure to FAD for as short as 24 hr 
caused a concentration-dependent reduction 
in the concentrations of E2 produced by ovary 
tissue held in culture for 12 hr (Figure 1A). 
Similarly, plasma concentrations of both E2 
and the estrogen-induced lipoprotein Vtg were 
significantly reduced within 24 hr of FAD 
exposure (Figure 1C, D). Previous studies in 
our laboratory have demonstrated that simi-
lar concentrations of FAD inhibit aromatase 
activity both in vitro and in vivo (Ankley 
et al. 2002; Villeneuve et al. 2006, 2007a). 
Consequently, we had little doubt that water-
borne exposure to FAD had a rapid, direct 
impact on aromatase-catalyzed E2 synthesis. 
Compensation. Results of this study sup-
ported previous observations that fathead 
minnows have the capacity to mount a com-
pensatory response to the direct, competitive 
inhibition of aromatase activity by increasing 
the transcription of CYP19A, presumably to 
increase synthesis of the enzyme (Villeneuve 
et al. 2006). Similar to our previous study in 
which concentration-dependent up-regulation 
of CYP19A gene expression was observed 
after 7 days of FAD exposure (Villeneuve et al. 
2006), CYP19A was also induced in the pres-
ent study. However, in the present study, this 
induction was time and concentration depen-
dent, with fish exposed to 30 µg FAD/L show-
ing significant induction earlier in the exposure 
than those exposed to 3 µg/L (Figure 3A). 
Significantly, results of this study also show a 
gradual recovery of ex vivo E2 production over 
the course of the exposure period at time points 
corresponding to those at which CYP19A gene 
expression was significantly elevated compared 
with control fish. In females exposed to 3 µg 
FAD/L, up-regu  lation of CYP19A expression 
and increases in ex vivo E2 production corre-
sponded with the return of plasma E2 concen-
trations to levels similar to those measured in 
controls. As a whole, these results are consistent 
with the hypothesis that increased CYP19A 
expression and presumably increased trans-
lation and abundance of aromatase A serve 
to offset competitive aromatase inhibition by 
FAD and that the inter  play between increased 
catalytic capacity and the availability (concen-
tration) of inhibitor controls whether or not 
this compensation succeeds. 
Results collected during the recovery period 
(days 9–16) provided further support for the 
hypothesis described above. Once the chemical 
was removed, ex vivo E2 production by FAD-
exposed fish generally exceeded that of control 
fish (Figure 1A). In the case of females exposed 
to 3 µg FAD/L, plasma E2 concentrations 
exceeded those in control females immediately 
after cessation of FAD delivery, suggesting a 
period of over  compensation corresponding 
with removal of the chemical. In females from 
the 30-µg/L group, plasma E2 concentrations 
rebounded rapidly once FAD delivery ceased. 
All of these data suggest that biosynthetic 
capacity for E2 production had increased in 
the FAD-exposed fish and that the continued 
presence of the inhibitor during the exposure 
phase, particularly at the 30-µg/L concentra-
tion, was limiting E2 production. 
Although CYP19A gene expression appears 
to play a key role in compensatory response to 
aromatase inhibition, we hypothesized that 
other genes involved in regulation of steroido-
genesis may also be modulated. For example, 
both StAR and CYP11A are thought to play 
rate-limiting roles in steroid biosynthesis, with 
StAR regulating the rate of cholesterol trans-
port to the inner mito  chondrial membrane 
and CYP11A catalyzing the conversion of 
cholesterol to pregnenolone, the first step in 
steroido  genesis (Miller 1988; Stocco 2001; 
Stocco and Clark 1996). Given these roles 
and previous observations that expression of 
CYP11A (males and females) and StAR (males 
only) was increased in the gonads of fathead 
minnows exposed to keto  conazole for 21 days 
(Ankley et al. 2007; Villeneuve et al. 2007b), 
we hypothesized that expression of these genes 
may increase in FAD-exposed females as a 
means to increase the overall rate of steroid 
biosynthesis. Results of the present study 
were consistent with this hypothesis. StAR 
expression was up-regulated in the ovaries of 
females exposed to 30 µg FAD/L for as little 
as 24 hr, and by the fourth day of exposure 
was increased in both FAD treatment groups 
(Figure 3D). By the eighth day of exposure 
and throughout the recovery period, StAR 
expression did not differ significantly from that 
in ovaries of control females. Statistically sig-
nificant induction of CYP11A lagged slightly 
behind that of StAR, but by the fourth day 
of exposure, there was clear induction in the 
fish exposed to 30 µg/L (Figure 3C). CYP11A 
expression in the ovaries of females exposed to 
3 µg/L peaked on the first day of the recov-
ery period (day 9), suggesting concentration-
dependence in the time course and profile of 
CYP11A expression in FAD-exposed females. 
Increases in mean ex vivo T production by 
ovary tissue collected from fish exposed to 
30 µg FAD/L followed a time-dependent pro-
file very similar to that of CYP11A and StAR 
expression, which suggests that up-regulation 
of these genes, and presumably increased trans-
lation of the corresponding proteins, may, in 
part, account for the increased T production 
we observed. However, that effect cannot be 
clearly discriminated from the reduced rate of 
converting T to E2 associated with aromatase 
inhibition. As a whole, however, StAR and 
CYP11A responses are consistent with a com-
pensatory response aimed at increasing the 
overall rate of steroid hormone synthesis.
In addition to genes coding for proteins 
regarded to have rate-limiting activities for ste-
roid synthesis, we hypothesized that exposure to 
FAD might modulate the expression of genes 
associated with feedback regulation of steroido-
genesis and reproductive development in the 
female fathead minnow. These included genes 
coding for AR, LHR, FSHR, activin βA, activin 
RIIB, PMR-α, and 20βHSD in the ovary and 
the gonadotropin β subunits and follistatin 
Figure 5. Relative abundance of mRNA transcripts coding for FSH-β (A), LHβ (B), and follistatin (C) measured in pituitary tissue from female fathead minnows 
exposed to 0 (control), 3, or 30 µg FAD/L and sampled on days 1, 4, or 8 of the exposure period. Data are expressed as fold-change (log 2) relative to the control 
mean measured on a given day; error bars indicate the SE for 5–8 replicate fish. 
*p < 0.05 for 3 µg FAD/L compared with control. #p < 0.05 for 30 µg FAD/L compared with control. 
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in the pituitary. By far, the most impacted of 
these transcripts was that coding for FSHR. 
We used PCA to examine correlations between 
14 ovary-related end points and their relative 
contributions to treatment-related variation. 
Based on PCA, FSHR expression, along with 
that of CYP19A, had the greatest influence on 
variation in the positive direction along fac-
tor 1 (as indicated by relative distance from the 
origin along the x-axis) (Figure 6A). Based on 
PCA and on relative expression or concentra-
tion profiles for the 30-µg/L treatment group, 
FSHR expression was nearly the mirror image 
of plasma Vtg (Figures 1C, 3B, 6A). In con-
trast, the profile of LHR expression was most 
similar to that of 20βHSD, an enzyme key to 
synthesis of 17α,20β-dihydroxy-4-pregnen-3-
one (17,20βP) (Nagahama 1997), and PMR-α, 
the receptor for 17,20βP (Thomas et al. 2002) 
(Figure 4). Together, 20βHSD, LHR, and, to a 
lesser extent, PMR-α had the greatest influence 
on variation in the positive direction along fac-
tor 2, whereas ex vivo and plasma E2 concen-
trations had the greatest negative influence on 
that factor (Figure 6A). AR, thought to play an 
important role in regulation of pre  vitellogenic 
oocyte growth (Lokman et al. 2007; Rohr et al. 
2001), also had a strong influence on variation 
along factor 1 and was more closely associated 
with the influence of FSHR and CYP11A on 
the PCA model than that of LHR expression 
(Figure 6A). The profiles of FSH-β and LH-β 
in pituitary tissue were similar to one another 
as a function of concentration and exposure 
duration (Figure 5). The associations revealed 
by both multi  variate PCA and expression/con-
centration profiles for individual variables are 
noteworthy relative to what is known about 
gonadotropins and their receptors in fish. 
In annual-spawning fish species such as 
salmonids, the gonadotropins FSH and LH 
appear to have functions similar to those in 
mammals. Specifically, FSH tends to be pre-
dominant during vitello  genesis and pre  ovulatory 
growth and correlated with aromatase expres-
sion and increasing E2 concentrations, whereas 
LH production tends to be low during vitello-
genesis but surges prior to ovulation, triggering 
increased synthesis of the maturation-inducing 
steroid 17,20βP, decreased aromatase expres-
sion, and final oocyte maturation (Luckenbach 
et al. 2008; Montserrat et al. 2004; Norris 
2007; Swanson et al. 2003; Yaron 1995). 
However, in female repeat-spawning fish with 
asynchronous oocyte development such as the 
fathead minnow, the gonadotropins appear to 
be expressed in parallel throughout reproductive 
development (Gen et al. 2000; Kagawa et al. 
2003; Kajimura et al. 2001; Villeneuve et al. 
2007d; Yaron 1995), yet still coordinate the 
processes of vitello  genesis, follicular growth, and 
final maturation. Additionally, in fish, FSHR 
appears to bind both LH and FSH, whereas 
LHR appears relatively specific for LH (Bogerd 
et al. 2001, 2005). Given this background, the 
profiles of gene expression in response to FAD 
treatment suggest that in repeat-spawning spe-
cies such as the fathead minnow, gonado  tropin 
receptor expression in ovarian cells may be an 
important regulator of asynchronous oocyte 
development and maturation. Assuming this to 
be the case, increased expression of FSHR can 
be viewed as both a compensatory response to, 
and consequence of, impaired estrogen synthe-
sis caused by FAD exposure.
Expression of the gonadotropins by the 
pituitary is regulated through negative feed-
back by the gonadal steroids (Yaron et al. 
2001, 2003) as well as both endocrine and 
autocrine/paracrine effects of activin and folli-
statin (Cheng et al. 2007; Ge 2000; Yuen and 
Ge 2004). Therefore, we hypothesized that 
expression of activin βA, activin RIIB, or fol-
listatin may be modulated in response to FAD 
exposure. Expression of activin βA, although 
significantly increased only on day 4, was the 
end point most closely associated with plasma 
E2 and ex vivo E2 production in the PCA model 
(Figure 6A). The gene coding for folli  statin, 
a protein known to bind to activin, thereby 
suppressing FSH-β expression (Yuen and Ge 
2004), was up-regulated only in fish exposed 
to 3 µg FAD/L and only after 24 hr of expo-
sure. These results suggest at least some modu-
lation of activin and follistatin in response to 
aromatase inhibition, but the overall relevance 
and role of that modulation relative to the other 
end points affected were not clear. 
Reproductively mature male fathead min-
nows generally do not have detectable testicular 
aromatase activity or ex vivo testicular E2 pro-
duction (Villeneuve DL, unpublished data); 
therefore, males were not the primary focus 
of this study. However, they do have some 
circulating E2 (≈ 0.4 ± 0.3 ng/mL) (Watanabe 
et al. 2007) and measurable brain aromatase 
activity that has been shown to be inhibited by 
FAD exposure (Ankley et al. 2002). Although 
the effect was not as pronounced as in females, 
there was a trend toward increased ex vivo T 
production and increased plasma T concen-
trations in males exposed to 30 µg FAD/L, 
which was broadly consistent with the impacts 
on ex vivo T production in females. We did 
not determine whether males had increases in 
CYP11A or StAR expression, as was observed 
in females. 
Recovery. Data from this experiment sug-
gested that a repeat-spawning fish species 
exposed to sublethal concentrations of an aro-
matase inhibitor for a short time would likely 
recover within several days after removal of the 
chemical. This was indicated by the rapid recov-
ery of plasma E2 concentrations to control lev-
els after cessation of FAD delivery (Figure 1C) 
and a trend toward recovering Vtg concentra-
tions. In both cases, recovery appeared to be 
concentration dependent, with fish exposed 
to 3 µg FAD/L showing some compensatory 
recovery while the exposure was ongoing, and 
those exposed to 30 µg/L recovering rapidly 
once FAD delivery ceased. A PCA-based scores 
trajectory plot also provided evidence of an 
overall concentration-dependent recovery. The 
mean scores for the control fish showed a tra-
jectory over the course of the experiment that 
traced a small loop (Figure 6B). By the first 
day of the exposure period, mean scores for 
both FAD treatment groups fell outside of the 
control trajectory loop. The greatest deviation 
from the control trajectory was observed on 
the fourth day of exposure for both FAD treat-
ment groups. However, after day 4, trajectories 
moved back in the direction of the control 
group. By the eighth day of the recovery period 
(day 16), mean scores for the 3-µg/L treat-
ment group were effectively contained within 
the loop of the control trajectory. Also, mean 
scores for the 30-µg/L group on the fourth day 
of recovery (day 12) were nearly identical to 
those observed for the 3-µg/L group on the first 
day of recovery (day 9), whereas those on the 
eighth day of recovery (day 16), were similar 
to those observed on the fourth day of recovery 
Figure 6. PCA of 14 variables analyzed in the ovaries of female fathead minnows exposed to 0 (control), 
3, or 30 µg FAD/L and sampled on days 1, 4, and 8 of the exposure period and on days 9, 12, and 16 of the 
recovery period. (A) Loadings plot showing relative influence of each variable on variation represented 
by positions along factor 1 (x) and factor 2 (y). Points near the origin exert relatively little influence; those 
farther from the origin exert greater influence. (B) Scores trajectory plot showing the mean x (factor 1) 
and y (factor 2) coordinates for each treatment group and time point. For clarity, x and y error bars are not 
shown here [the same plot with error bars is available in Supplemental Material, Figure 1 (available online 
at http://www.ehponline.org/members/2009/11891/suppl.pdf)]. 
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(day 12) in the 3-µg/L group. Thus, our data 
support the conclusion that recovery is possible 
and that the time course of compensation and 
recovery was concentration dependent.
Conclusions
Studies conducted with FAD and other aro-
matase-inhibiting chemicals have led to the 
formulation of a conceptual toxicity pathway 
model for the effects of these chemicals on fish 
reproduction. Specifically, the direct action of 
FAD inhibits aromatase activity in females, lead-
ing to significant declines in rates of E2 synthesis, 
plasma E2 concentrations, Vtg expression in the 
liver, and plasma Vtg concentrations, as well as 
reduced uptake of Vtg into developing oocytes, 
and ultimately reduced fecundity (Ankley et al. 
2002; Villeneuve et al. 2006, 2008, the pres-
ent study). Compensatory responses to aro-
matase inhibition include increased expression 
of transcripts coding for aromatase A, proteins 
thought to be rate limiting for steroido  genesis 
(e.g., StAR, CYP11A), and FSHR as a potential 
key regulator of vitello  genesis and preovulatory 
development in the ovary of repeat-spawning 
female fish. These compensatory responses 
appear capable of offsetting the direct effects of 
the chemical, but the time course and efficacy 
of compensation is dependent on the chemi-
cal concentration. Further, after the inhibitor is 
removed, fish appear able to recover from the 
effects of the perturbation, but the time course 
of recovery is concentration dependent and may 
also vary with the duration of exposure. Similar 
time-course experiments with other steroido-
genesis inhibitors should help establish whether 
the observations made in this study are general-
ized responses to steroidogenesis inhibition or 
disruption of vitellogenesis, or whether they are 
specific to aromatase inhibition, thereby helping 
to define the overall applicability of this toxicity 
pathway model. 
Additionally, the results of this study 
have significant implications relative to the 
develop  ment of short-term testing protocols or 
biomarkers for detecting and identifying endo-
crine-disrupting chemicals (or other sub  lethal 
toxicants). For example, based on ex vivo E2 
production results alone, a 24-hr test protocol 
would have identified FAD as a likely endo-
crine disruptor, whereas an 8-day test protocol 
would not. Because of their rapid, sensitive, and 
persistent responses, end points such as plasma 
Vtg or ovarian FSHR or CYP19A expression 
would likely have greater utility as biomarkers 
than other end points that show more transient 
responses either during exposure or recovery. 
Development of robust toxicity pathway mod-
els that incorporate compensation and recovery 
mechanisms should aid in predicting toxico-
logic outcomes after exposure to specific classes 
of toxicants. 
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